
Clariant Denies Dow Europe’s Competition Law Allegations in €767 Million Claim
Clariant firmly denies Dow Europe’s 2020 competition law allegations against four chemical companies.

Clariant firmly denies Dow Europe’s 2020 competition law allegations against four chemical companies.

Exclusive licensing and R&D collaboration between Hovione and Firstgene.

Construction Begins on Ineos’ Project Greensand CO₂ Transit Terminal at Port Esbjerg

Aenova announces the launch of its Aenovation program. This initiative aims to accelerate the early development of pharmaceutical formulations.

Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), has licensed ATUM’s proprietary Leap-In Transposase transposon-based gene delivery and its miCHO cell line development technologies.

For sustainable food packaging, Metpack is now offering coated paper and cardboard that is home compostable.

MSSA, part of the International Chemical Investors Group (ICIG), announced the expansion of its sodium methylate production unit at its La Rochelle, France, site.

PCI Pharma Services has completed its acquisition of Ajinomoto Althea, a CDMO subsidiary of Ajinomoto.

Roquette completes IFF Pharma Solutions acquisition and unveils new structure for global growth and innovation.

MSD receives a non-exclusive license for Cyprumed's drug delivery technology for developing oral peptide therapeutics.

Perstorp and BRB, subsidiaries of Petronas Chemicals Group (PCG), inaugurated an innovation hub in Shanghai, China. The laboratory will support growth in the region by increasing technical support for customers.

Ineos and Covestro announced a significant long-term agreement for the natural gas supply for up to eight years, starting in 2027.

Merck Wilmington Biotech will serve as a launch and commercial production facility and the future US home for Keytruda.

Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.

Merck and biopharmaceutical company SpringWorks Therapeutics, have entered into a definitive agreement for Merck to acquire SpringWorks.

Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, to succeed Richard Packer as Head of Healthcare.

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced a 10-year manufacturing supply agreement, valued at over $3 billion (€2.64 billion), with Regeneron Pharmaceuticals to provide US-based production of its industry-leading biologic medicines, which treat millions of patients worldwide.

What happens when over 300 pharmaceutical leaders from across Europe and beyond gather in Berlin? Insightful discussions, strategic collaboration and opinions exchange — all under one roof. The 5th edition of the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP), held on 14–15 April, brought together decision-makers from across the pharmaceutical value chain to explore the technologies, trends and innovations shaping drug production and packaging.

Roche recently announced that it will invest $50 billion (€43.8 billion) into the United States in the next five years.

CDMO Suanfarma appoints Pere Mañé Godina as its new CEO, marking the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion.

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Thermo Fisher Scientific recently announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, California, US.

Shashank Deshpande, member of the Board of Managing Directors, has been appointed Chairman of the Board of Managing Directors.

Shilpa Medicare has received approval from India’s top drug authorities to move forward with its new IND - Nor-Ursodeoxycholic Acid (500 mg).

AC Biode developed a diverse portfolio of products based on chemical technology designed to provide more sustainable alternatives to conventional practices.

The awards are designed to recognise pioneering ideas and showcase the vital role vinyl plays.

Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions, has launched today with an extensive integrated network across Europe.

Scientifica Venture Capital, in collaboration with the Institut des Relations Economiques France-Italie (IREFI), has unveiled the winners of the Super Sapiens Europe initiative.

To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure.

Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.

Strategic Value Partners (SVP) and Blantyre Capital Limited (Blantyre) recently announced the acquisition of OQ Chemicals (Oxea), a leading global producer and merchant of oxo chemicals.

Ethris and Lonza have teamed up to develop room-temperature stable, spray-dried mRNA vaccines for respiratory diseases. This collaboration aims to create mucosal delivery formulations, offering a promising new approach to combat respiratory illnesses.

Solvay has officially inaugurated its rare earths production line for permanent magnets at the La Rochelle facility, marking a significant milestone in the Group’s commitment to meeting Europe’s strategic goals.

Oncodesign Services has appointed Aidan Synnott as chief executive officer to help strengthen its position as a trusted partner in drug discovery.